Nathalie Bastien
Overview
Explore the profile of Nathalie Bastien including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
114
Citations
5439
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Signore A, Joseph T, Ranadheera C, Erdelyan C, Alkie T, Raj S, et al.
Emerg Microbes Infect
. 2025 Feb;
14(1):2469643.
PMID: 39964293
We report the detection of a clade 2.3.4.4b A(H5N1) reassortant virus with a neuraminidase surface protein derived from a North American lineage low-pathogenic avian influenza virus. This virus caused a...
2.
Separovic L, Zhan Y, Kaweski S, Sabaiduc S, Carazo S, Olsha R, et al.
Euro Surveill
. 2025 Jan;
30(4).
PMID: 39885824
The Canadian Sentinel Practitioner Surveillance Network (SPSN) reports interim 2024/25 vaccine effectiveness (VE) against acute respiratory illness due to laboratory-confirmed influenza during a delayed season of predominant A(H1N1)pdm09 and lower...
3.
Jassem A, Roberts A, Tyson J, Zlosnik J, Russell S, Caleta J, et al.
N Engl J Med
. 2024 Dec;
392(9):927-929.
PMID: 39740022
No abstract available.
4.
Ben Moussa M, Nwosu A, Schmidt K, Buckrell S, Rahal A, Lee L, et al.
Can Commun Dis Rep
. 2024 Nov;
50(11):393-399.
PMID: 39525075
The 2023-2024 influenza epidemic saw the return of typical late-season influenza B circulation. The epidemic was declared in week 45 (week ending November 11, 2023) due to the predominant circulation...
5.
Schmidt K, Ben Moussa M, Buckrell S, Rahal A, Chestley T, Bastien N, et al.
Can Commun Dis Rep
. 2024 Mar;
49(10):413-424.
PMID: 38476926
Coinciding with the beginning of the coronavirus disease 2019 (COVID-19) pandemic in March 2020, Canadian seasonal influenza circulation was suppressed, which was a trend reported globally. Canada saw a brief...
6.
Skowronski D, Zhan Y, Kaweski S, Sabaiduc S, Khalid A, Olsha R, et al.
Euro Surveill
. 2024 Feb;
29(7).
PMID: 38362622
The Canadian Sentinel Practitioner Surveillance Network reports mid-season 2023/24 influenza vaccine effectiveness (VE) of 63% (95% CI: 51-72) against influenza A(H1N1)pdm09, lower for clade 5a.2a.1 (56%; 95% CI: 33-71) than...
7.
Buckrell S, Ben Moussa M, Bui T, Rahal A, Schmidt K, Lee L, et al.
Can Commun Dis Rep
. 2023 Dec;
48(10):473-483.
PMID: 38125392
Canadian seasonal influenza circulation had been suppressed since the beginning of the coronavirus disease 2019 (COVID-19) pandemic. This suppression was reported globally and generated concern that the return of community...
8.
Bourdeau M, Vadlamudi N, Bastien N, Embree J, Halperin S, Jadavji T, et al.
JAMA Netw Open
. 2023 Oct;
6(10):e2336863.
PMID: 37792376
Importance: Respiratory syncytial virus (RSV) is a leading cause of pediatric hospitalizations. Objective: To describe the epidemiology and burden of RSV-associated hospitalizations among children and adolescents in Canadian tertiary pediatric...
9.
Ben Moussa M, Buckrell S, Rahal A, Schmidt K, Lee L, Bastien N, et al.
Can Commun Dis Rep
. 2023 Feb;
49(1):10-14.
PMID: 36815865
Canada's 2022-2023 national influenza epidemic was declared in epidemiological week 43 (week ending October 29, 2022), relatively early in comparison to historical seasons. This year marks the return to pre-pandemic-like...
10.
Skowronski D, Chuang E, Sabaiduc S, Kaweski S, Kim S, Dickinson J, et al.
Euro Surveill
. 2023 Feb;
28(5).
PMID: 36729117
The Canadian Sentinel Practitioner Surveillance Network estimated vaccine effectiveness (VE) during the unusually early 2022/23 influenza A(H3N2) epidemic. Like vaccine, circulating viruses were clade 3C.2a1b.2a.2, but with genetic diversity affecting...